Every earnings call for PIIND — management tone, guidance, KPIs and promise tracking, quarter by quarter.
PIIND · 5 transcripts · Chemicals · latest Q4 FY26PI Industries Limited has 5 earnings calls on record here, a Chemicals company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Consolidated Revenue (FY26) ₹6,714 cr; EBITDA Margin (FY26) 25.0%; Gross Margin (FY26) 58.0%. Full year FY26 consolidated revenue reached ₹6,713.7 crores.
Read full transcript & analysisRevenue ₹1,376 cr; EBITDA Margin (9M) 27.0%; Gross Margin 59.0%. Pharma business delivered 50% year-on-year growth over nine months.
Read full transcript & analysisRevenue 18723 million (−16% YoY). Revenue declined 16% YoY to ₹18,723 million in Q2 FY26.
Read full transcript & analysisRevenue 19005 million (−8% YoY); EBITDA Margin 27.5%; Gross Margin 57.4%. Pharma business revenue grew 186% YoY.
Read full transcript & analysisRevenue ₹1,787 cr (+3% YoY); EBITDA Margin 25.6%. Q4 FY25 revenue grew 3% YoY to ₹1,787.1 crores, with full year FY25 revenue up 4% to ₹7,977.8 crores.
Read full transcript & analysis